Brief: Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule
04/03/2024 15:08
March 4 (Reuters) - Ligand Pharmaceuticals Inc LGND.O :
* LIGAND PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER
NASDAQ
LISTING RULE 5635(C)(4)
Source text for Eikon: ID:nBw7Sr5zya
Further company coverage: LGND.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ligand Pharmaceuticals Incorporated
See all newsBrief: Ligand Acquires Royalty And Milestone Interest In Santen’s Ryjunea From Sydnexis For $23 Million
Ligand Pharmaceuticals Incorporated reports results for the quarter ended June 30 - Earnings Summary
Ligand Pharmaceuticals Q2 revenue rises on royalty growth
Brief: Ligand Pharmaceuticals Q2 EPS USD 2.22
U.S. RESEARCH ROUNDUP-Equinix, Goldman Sachs, JPMorgan